Home » Newsletters » BioWorld Science

BioWorld Science

June 6, 2019

View Archived Issues

FDA clears IND for NantKwest's CD19.t-haNK cell therapy

GlaxoSmithKline initiates phase I study of HBV therapeutic vaccines

Pfizer initiates phase II study of PF-06700841 topical cream for atopic dermatitis

First-in-human data presented for TAS-119

TVB-2640 in combination with bevacizumab results in promising PFS in patients with recurrent GBM

Phase I data for CC-90010 in patients with advanced solid tumors and non-Hodgkin's lymphoma

Clinical study foreseen for Immunic's autoimmune disease candidate IMU-935

Microbiome metabolism influences drug responses

Novel ruthenium(II) complex induces apoptosis and inhibits angiogenesis in tumor animal models

Rifamycin SV-MMX evaluated in phase II study for acute uncomplicated diverticulitis

Promising results of phase I trial of CAL-02 in severe community-acquired pneumococcal pneumonia

TXNRD1 blockade found to play protective role in acute lung injury

New gene variants found to protect against osteoporosis in patients with Gaucher's disease

Phase III ELEVATE-TN trial of Calquence in previously untreated CLL meets primary endpoint

Asclepius initiates phase I/II study of BCMA CAR-NK cells in relapsed/refractory multiple myeloma

Partial response observed in ongoing phase II study of BN-Brachyury for chordoma

Phase III study of Ninlaro in systemic AL amyloidosis misses first of two primary endpoints

Vaccitech initiates phase IIb study of MVA-NP+M1 universal flu vaccine in Belgium

Concert Pharmaceuticals presents phase I preliminary data for CTP-692

Novartis discovers HBsAg secretion inhibitors

New mGlu2 negative allosteric modulators synthesized at Sumitomo Dainippon Pharma

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

Hepagene Therapeutics patents MEK kinase 5 inhibitors

Metabomed identifies acetyl-coenzyme A synthetase, cytoplasmic inhibitors

InflaRx reports topline results from phase IIb SHINE study of IFX-1 in hidradenitis suppurativa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...